Skip to main content
HIMS
NYSE Life Sciences

FDA Considers Broader Peptide Access, Analysts See Long-Term Growth for Hims

Tom Rudovsky · Reported by Reuters
More coverage: Household Product Stocks · Consumer
Sentiment info
Positive
Importance info
8
Price
$26.325
Mkt Cap
$6B
52W Low
$13.74
52W High
$70.43
52W Position info
92% above low
Off High info
63% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

HIMS sits 92% above its 52-week low of $13.74.

Summary

The FDA's consideration to ease restrictions on compounding pharmacies manufacturing certain peptides is viewed as a significant long-term positive for Hims & Hers Health. This potential regulatory shift could open new revenue streams and growth avenues for the company, especially as its personalized GLP-1 compounding opportunities dissipate. Analysts highlight that Hims, which previously offered compounded GLP-1s and acquired a peptide facility last year, is well-positioned to leverage this change. While not an immediate revenue driver, this development provides a crucial catalyst for future growth and allows Hims to utilize its existing infrastructure, addressing a potential "growth hole" identified by analysts. The next step to watch is the FDA panel's recommendation and subsequent alignment.

At the time of this announcement, HIMS was trading at $26.33 on NYSE in the Life Sciences sector, with a market capitalization of approximately $6B. The 52-week trading range was $13.74 to $70.43. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

HIMS - Latest Insights

HIMS
Nov 11, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $19.00
Real-time Price: $19.41 info
Change: +$0.4133 (+2%) info
Market Cap: $4.603B info
HIMS
Nov 10, 2026, 1:54 PM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $18.85
Real-time Price: $19.41 info
Change: +$0.5668 (+3%) info
Market Cap: $4.603B info
HIMS
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $22.16
Real-time Price: $19.41 info
Change: -$2.75 (-12%) info
Market Cap: $4.603B info
HIMS
Nov 09, 2026, 5:52 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.33
Real-time Price: $19.41 info
Change: -$2.92 (-13%) info
Market Cap: $4.603B info
HIMS
Nov 09, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.39
Real-time Price: $19.41 info
Change: -$3.98 (-17%) info
Market Cap: $4.603B info